UC96:LSE:LSE-UBS (Irl) ETF plc - Factor MSCI USA Prime Value UCITS ETF (USD) A-dis (GBX)

ETF | Others |

Last Closing

USD 2751.5

Change

+17.50 (+0.64)%

Market Cap

USD 0.26B

Volume

1.06K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 321.87B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing UC96:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.40% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.40% 59% D- 61% D-
Trailing 12 Months  
Capital Gain 14.28% 68% D+ 68% D+
Dividend Return 0.00% 1% F 2% F
Total Return 14.28% 68% D+ 67% D+
Trailing 5 Years  
Capital Gain 59.76% 76% C+ 79% B-
Dividend Return 0.02% 11% F 7% C-
Total Return 59.78% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.19% 70% C- 72% C
Dividend Return 10.20% 70% C- 71% C-
Total Return 0.00% 14% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 10.66% 62% D 77% C+
Risk Adjusted Return 95.63% 96% N/A 97% N/A
Market Capitalization 0.26B 58% F 44% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.